Table 4.
Risk for biochemical (PSA) failure based on risk groups.
| Risk groups | # patients (%) | |
|---|---|---|
| Low | No or one intermediate-risk factor | 373 (64%) |
| Intermediate | Two intermediate-risk factors | 112 (19%) |
| High | Gleason >7 or PSA >20 or all 3 intermediate-risk factors | 96 (17%) |
Low-risk factors: Gleason <7, PSA <10 ng/ml, and mar/epe negative. Intermediate-risk factors: Gleason 7, PSA 10–20 ng/ml, and mar/epe positive. High-risk factors: Gleason 8–10 and PSA >20 ng/ml.